Feed BXMX
BX

Nuveen S&P 500 Buy-Write Income Fund BXMX · NYSE

$13.26 -2.07% (-$0.28)

Summary

63 / 100 · Bulios Score

What speaks for it

  • Out of every 100 USD of revenue, 1,019 USD is left as net profit.
  • The 8.2% dividend yield is well covered: it takes 49% of profit.

What to watch

  • Revenue fell by 9.8% a year over the last 3 years.
  • The share price is above the Bulios Fair Price.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks expensive

Price against the Bulios Fair Price

P/E against the industry (Asset Management - Income)

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 6.0 USD for 1 USD of yearly profit.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Revenue fell by 36% a year over 5 years. Over the last 3 years it fell by 9.8% a year.

Growth in detail

Does it make money?

Income figures for the last 12 months are not available.

Profitability in detail

Is it financially healthy?

Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.

Financial health in detail

Does it pay a dividend?

High, safe
Yield
8.22%
Paid out of profit
49%
Raised in a row
2 years

You receive $0.82 per share a year. The company covers the payout with ease.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

100% of the analysts recommend buying.

Analysts in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.